Page 6 - Vaxart The News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vaxart the. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vaxart The Today - Breaking & Trending Today

Vaxart Appoints W. Mark Watson to its Board of Directors

Vaxart Appoints W. Mark Watson to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Roberta Yedid , Karen Wilson , Mark Herr , Toddc Davis , Andrew Blazier , Andrei Floroiu , W Mark Watson , Audit Committee Of Inhibitor Therapeutics Inc , Company Board Of Directors , Audit Committee Of Sykes Enterprises Inc , American Institute Of Certified Public Accountants , Audit Committee , Florida Institute Of Certified Public Accountants , Chairperson Of The Audit Committee , Vaxart Inc , Marquette University , Company Audit Committee , Biodelivery Sciences International Inc , Deloitte Touche Tohmatsu , Interim Chairperson , Chief Executive , Vaxart Board Chairman Todd , Certified Public Accountant , Central Florida Marketplace , Inhibitor Therapeutics ,

Vaxart Provides Business Update and Reports Second Quarter 2022 Financial Results

Vaxart Provides Business Update and Reports Second Quarter 2022 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Mark Herr , Andrew Blazier , Andrei Floroiu , Exchange Commission On , World Health Organization , Drug Administration , Vaxart Inc Condensed Consolidated Balance Sheets , Product Development For Vaccines Advisory Committee , Hvivo Services , Vaxart Inc , Duke University , Chief Executive , Wuhans Only , Science Translational Medicine , Open Orphan , Challenge Trial , Clinical Milestones , Human Challenge Trial , Three Months Ended , Callthe Vaxart , Product Development , Vaccines Advisory Committee , Regarding Forward Looking Statements This , Annual Reports ,

Vaxart (VXRT) Reports Additional Phase 1 Data Suggesting its Oral COVID-19 Pill Vaccine Candidate Induces Long-Lasting Mucosal Immune Responses that are Highly Cross-Reactive

Vaxart (VXRT) Reports Additional Phase 1 Data Suggesting its Oral COVID-19 Pill Vaccine Candidate Induces Long-Lasting Mucosal Immune Responses that are Highly Cross-Reactive
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

James Cummings , Sean Tucker , Vaxart Inc , Vaxart Media Relationsmark Herrvaxart Inc , Chief Scientific , Chief Medical Officer , Regarding Forward Looking Statementsthis , Annual Reports , Media Relationsmark Herrvaxart ,

Critical Survey: Vaxart (NASDAQ:VXRT) versus Surface Oncology (NASDAQ:SURF)

Vaxart (NASDAQ:VXRT – Get Rating) and Surface Oncology (NASDAQ:SURF – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends. Risk & Volatility Vaxart has a beta of 0.67, indicating […] ....

United States , United Kingdom , South San Francisco , Vaccinex Inc , Surface Oncology Inc , Vaxart Inc , Get Rating , Surface Oncology , Given Surface Oncology , Glaxosmithkline Intellectual Property , Nasdaq Vxrt , Stock Comparison , Stock Analysis ,

Analysts Anticipate Vaxart, Inc. (NASDAQ:VXRT) Will Post Quarterly Sales of $100,000.00

Equities research analysts predict that Vaxart, Inc. (NASDAQ:VXRT – Get Rating) will post sales of $100,000.00 for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Vaxart’s earnings, with the lowest sales estimate coming in at $90,000.00 and the highest estimate coming in at $100,000.00. Vaxart reported sales of $110,000.00 […] ....

United States , Rafferty Asset Management , Zacks Investment Research , Vaxart Inc , De Shaw Co , America Corp , Citigroup Inc , Get Rating , Investment Research , Street Corp , Asset Management , Nasdaq Vxrt ,